Sarasin & Partners LLP Zoetis Inc. Transaction History

Sarasin & Partners LLP

$8.99 Billion
Q1 2025

A detailed history of Sarasin & Partners LLP transactions in Zoetis Inc. stock. As of the latest transaction made, Sarasin & Partners LLP holds 1,553,855 shares of ZTS stock, worth $242 Million. This represents 2.85% of its overall portfolio holdings.

Number of Shares

1,553,855

Previous 2,059,588 24.56%

Holding current value

$242 Million

Previous $339 Million 24.56%

% of portfolio

2.85%

Previous 3.39%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 15, 2025	SELL	$156.48 - $175.67 $79.1 Million - $88.8 Million	-505,733 Reduced 24.56%	1,553,855 $256 Million
Q1 2025 Apr 09, 2025	BUY	$156.48 - $175.67 $322 Million - $362 Million	2,059,588 New	2,059,588 $339 Million
Q3 2024 Oct 09, 2024	SELL	$172.58 - $196.48 $33.5 Million - $38.1 Million	-194,002 Reduced 8.61%	2,059,588 $402 Million
Q2 2024 Jul 19, 2024	BUY	$145.54 - $178.83 $277 Million - $341 Million	1,904,899 Added 546.3%	2,253,590 $391 Million
Q1 2024 Apr 12, 2024	BUY	$165.67 - $199.94 $23.6 Million - $28.5 Million	142,496 Added 69.11%	348,691 $59 Million
Q4 2023 Jan 09, 2024	SELL	$151.44 - $200.09 $4,997 - $6,602	-33 Reduced 0.02%	206,195 $40.7 Million
Q3 2023 Oct 05, 2023	BUY	$167.14 - $192.77 $8.81 Million - $10.2 Million	52,691 Added 34.32%	206,228 $35.9 Million
Q2 2023 Jul 10, 2023	BUY	$160.94 - $186.23 $5.98 Million - $6.92 Million	37,167 Added 31.94%	153,537 $26.4 Million
Q1 2023 May 05, 2023	SELL	$145.48 - $175.02 $7.69 Million - $9.25 Million	-52,854 Reduced 31.23%	116,370 $19.4 Million
Q1 2023 Apr 27, 2023	BUY	$145.48 - $175.02 $6.63 Million - $7.97 Million	45,562 Added 36.84%	169,224 $28.2 Million
Q4 2022 Jan 30, 2023	SELL	$131.14 - $157.47 $148,843 - $178,728	-1,135 Reduced 0.91%	123,662 $18.1 Million
Q3 2022 Oct 18, 2022	BUY	$148.29 - $182.55 $741,450 - $912,750	5,000 Added 4.17%	124,797 $18.5 Million
Q2 2022 Jul 13, 2022	SELL	$155.97 - $200.09 $1.6 Million - $2.06 Million	-10,288 Reduced 7.91%	119,797 $20.6 Million
Q1 2022 Apr 11, 2022	SELL	$181.39 - $234.03 $12.3 Million - $15.9 Million	-67,855 Reduced 34.28%	130,085 $24.5 Million
Q2 2021 Jul 13, 2021	BUY	$155.9 - $187.99 $10 Million - $12.1 Million	64,154 Added 47.95%	197,940 $36.9 Million
Q1 2021 Apr 29, 2021	BUY	$144.0 - $169.39 $7.58 Million - $8.91 Million	52,611 Added 64.81%	133,786 $21.1 Million
Q3 2020 Nov 09, 2020	BUY	$137.1 - $165.37 $2.03 Million - $2.45 Million	14,839 Added 22.37%	81,175 $13.4 Million
Q1 2020 Apr 30, 2020	BUY	$92.66 - $144.94 $696,525 - $1.09 Million	7,517 Added 12.78%	66,336 $7.81 Million
Q3 2019 Nov 08, 2019	BUY	$112.57 - $128.43 $1.11 Million - $1.27 Million	9,873 Added 20.17%	58,819 $7.33 Million
Q2 2019 Jul 18, 2019	BUY	$97.98 - $114.28 $208,207 - $242,845	2,125 Added 4.54%	48,946 $5.56 Million
Q4 2018 Feb 12, 2019	SELL	$79.28 - $95.27 $459,269 - $551,899	-5,793 Reduced 11.01%	46,821 $4.01 Million
Q3 2018 Nov 09, 2018	BUY	$83.5 - $93.23 $4.39 Million - $4.91 Million	52,614 New	52,614 $4.82 Million

Others Institutions Holding ZTS

# of Institutions

2,075

Shares Held

416M

Call Options Held

1.22M

Put Options Held

1.61M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $72.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sarasin & Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Sarasin & Partners LLP with notifications on news.

Account

Sarasin & Partners LLP Zoetis Inc. Transaction History